BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abramson A, Caffarel-Salvador E, Khang M, Dellal D, Silverstein D, Gao Y, Frederiksen MR, Vegge A, Hubálek F, Water JJ, Friderichsen AV, Fels J, Kirk RK, Cleveland C, Collins J, Tamang S, Hayward A, Landh T, Buckley ST, Roxhed N, Rahbek U, Langer R, Traverso G. An ingestible self-orienting system for oral delivery of macromolecules. Science 2019;363:611-5. [PMID: 30733413 DOI: 10.1126/science.aau2277] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 39.3] [Reference Citation Analysis]
Number Citing Articles
1 Zuberi Z, Sauli E, Cun L, Deng J, Li WJ, He XL, Li W. Insulin-delivery methods for children and adolescents with type 1 diabetes. Ther Adv Endocrinol Metab 2020;11:2042018820906016. [PMID: 32944212 DOI: 10.1177/2042018820906016] [Reference Citation Analysis]
2 Søgaard PP, Lind M, Christiansen CR, Petersson K, Clauss A, Caffarel-Salvador E. Future Perspectives of Oral Delivery of Next Generation Therapies for Treatment of Skin Diseases. Pharmaceutics 2021;13:1722. [PMID: 34684016 DOI: 10.3390/pharmaceutics13101722] [Reference Citation Analysis]
3 Iacovacci V, Tamadon I, Kauffmann EF, Pane S, Simoni V, Marziale L, Aragona M, Cobuccio L, Chiarugi M, Dario P, Del Prato S, Ricotti L, Vistoli F, Menciassi A. A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules. Sci Robot 2021;6:eabh3328. [PMID: 34408097 DOI: 10.1126/scirobotics.abh3328] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Juère E, Caillard R, Marko D, Del Favero G, Kleitz F. Smart Protein-Based Formulation of Dendritic Mesoporous Silica Nanoparticles: Toward Oral Delivery of Insulin. Chemistry 2020;26:5195-9. [PMID: 32057143 DOI: 10.1002/chem.202000773] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
5 Xu N, Ruan G, Liu W, Hu C, Huang A, Zeng Z, Luo S, Zhang Z, Fan M, Ye F, Xi T, Xing Y. Vaccine-induced gastric CD4+ tissue-resident memory T cells proliferate in situ to amplify immune response against Helicobacter pylori insult. Helicobacter 2019;24:e12652. [PMID: 31414552 DOI: 10.1111/hel.12652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Lángi Z. A solution to some problems of Conway and Guy on monostable polyhedra. Bulletin of London Math Soc. [DOI: 10.1112/blms.12579] [Reference Citation Analysis]
7 Wang Z, Wang J, Kahkoska AR, Buse JB, Gu Z. Developing Insulin Delivery Devices with Glucose Responsiveness. Trends Pharmacol Sci 2021;42:31-44. [PMID: 33250274 DOI: 10.1016/j.tips.2020.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
8 Chang R, Chen JL, Zhang GY, Li Y, Duan HZ, Luo SZ, Chen YX. Intrinsically Disordered Protein Condensate-Modified Surface for Mitigation of Biofouling and Foreign Body Response. J Am Chem Soc 2022;144:12147-57. [PMID: 35767424 DOI: 10.1021/jacs.2c02677] [Reference Citation Analysis]
9 Chen W, Wainer J, Ryoo SW, Qi X, Chang R, Li J, Lee SH, Min S, Wentworth A, Collins JE, Tamang S, Ishida K, Hayward A, Langer R, Traverso G. Dynamic omnidirectional adhesive microneedle system for oral macromolecular drug delivery. Sci Adv 2022;8:eabk1792. [PMID: 34985942 DOI: 10.1126/sciadv.abk1792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Drucker DJ. Transforming type 1 diabetes: the next wave of innovation. Diabetologia 2021;64:1059-65. [PMID: 33550440 DOI: 10.1007/s00125-021-05396-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang L, Yang J, Li S, Li Q, Liu S, Zheng W, Jiang X. Oral Administration of Starting Materials for In Vivo Synthesis of Antibacterial Gold Nanoparticles for Curing Remote Infections. Nano Lett 2021;21:1124-31. [DOI: 10.1021/acs.nanolett.0c04578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Zhang Z, Shang L. Smart ingestible devices: Orally delivering macromolecules and beyond. Matter 2021;4:3379-81. [DOI: 10.1016/j.matt.2021.10.003] [Reference Citation Analysis]
13 Eleftheriadis GK, Genina N, Boetker J, Rantanen J. Modular design principle based on compartmental drug delivery systems. Adv Drug Deliv Rev 2021;178:113921. [PMID: 34390776 DOI: 10.1016/j.addr.2021.113921] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
14 Yang W, Gadgil P, Krishnamurthy VR, Landis M, Mallick P, Patel D, Patel PJ, Reid DL, Sanchez-felix M. The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules. AAPS J 2020;22. [DOI: 10.1208/s12248-019-0402-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
15 Hu C, Liu W, Xu N, Huang A, Zeng Z, Luo S, Zhang Z, Fan M, Ye F, Xi T, Xing Y. Perivascular Lymphocyte Clusters Induced by Gastric Subserous Layer Vaccination Mediate Optimal Immunity against Helicobacter through Facilitating Immune Cell Infiltration and Local Antibody Response. J Immunol Res 2020;2020:1480281. [PMID: 32411786 DOI: 10.1155/2020/1480281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Finbloom JA, Sousa F, Stevens MM, Desai TA. Engineering the drug carrier biointerface to overcome biological barriers to drug delivery. Adv Drug Deliv Rev 2020;167:89-108. [PMID: 32535139 DOI: 10.1016/j.addr.2020.06.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 16.0] [Reference Citation Analysis]
17 Mau MM, Sarker S, Terry BS. Ingestible devices for long-term gastrointestinal residency: a review. Prog Biomed Eng 2021;3:042001. [DOI: 10.1088/2516-1091/ac1731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Byrne J, Huang HW, McRae JC, Babaee S, Soltani A, Becker SL, Traverso G. Devices for drug delivery in the gastrointestinal tract: A review of systems physically interacting with the mucosa for enhanced delivery. Adv Drug Deliv Rev 2021;177:113926. [PMID: 34403749 DOI: 10.1016/j.addr.2021.113926] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
19 Abramson A, Dellal D, Kong YL, Zhou J, Gao Y, Collins J, Tamang S, Wainer J, McManus R, Hayward A, Frederiksen MR, Water JJ, Jensen B, Roxhed N, Langer R, Traverso G. Ingestible transiently anchoring electronics for microstimulation and conductive signaling. Sci Adv 2020;6:eaaz0127. [PMID: 32923616 DOI: 10.1126/sciadv.aaz0127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Abramson A, Halperin F, Kim J, Traverso G. Quantifying the Value of Orally Delivered Biologic Therapies: A Cost-Effectiveness Analysis of Oral Semaglutide. J Pharm Sci 2019;108:3138-45. [PMID: 31034907 DOI: 10.1016/j.xphs.2019.04.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
21 Zhao C, Cai L, Chen H, Tan H, Yan D. Oral biomaterials for intestinal regulation. Engineered Regeneration 2021;2:116-32. [DOI: 10.1016/j.engreg.2021.09.002] [Reference Citation Analysis]
22 Sittadjody S, Opara EC. Encapsulation Strategies for Pancreatic Islet Transplantation without Immune Suppression. Curr Stem Cell Rep 2021;7:49-71. [DOI: 10.1007/s40778-021-00190-w] [Reference Citation Analysis]
23 Liu W, Zeng Z, Luo S, Hu C, Xu N, Huang A, Zheng L, Sundberg EJ, Xi T, Xing Y. Gastric Subserous Vaccination With Helicobacter pylori Vaccine: An Attempt to Establish Tissue-Resident CD4+ Memory T Cells and Induce Prolonged Protection. Front Immunol 2019;10:1115. [PMID: 31156652 DOI: 10.3389/fimmu.2019.01115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
24 Qin Y, Lao YH, Wang H, Zhang J, Yi K, Chen Z, Han J, Song W, Tao Y, Li M. Combatting Helicobacter pylori with oral nanomedicines. J Mater Chem B 2021;9:9826-38. [PMID: 34854456 DOI: 10.1039/d1tb02038b] [Reference Citation Analysis]
25 Krause J, Brokmann F, Rosenbaum C, Weitschies W. The challenges of drug delivery to the esophagus and how to overcome them. Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2033206] [Reference Citation Analysis]
26 Panou DA, Diedrichsen RG, Kristensen M, Nielsen HM. Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery. Methods Mol Biol 2022;2383:371-84. [PMID: 34766302 DOI: 10.1007/978-1-0716-1752-6_24] [Reference Citation Analysis]
27 Brown TD, Whitehead KA, Mitragotri S. Materials for oral delivery of proteins and peptides. Nat Rev Mater 2020;5:127-48. [DOI: 10.1038/s41578-019-0156-6] [Cited by in Crossref: 74] [Cited by in F6Publishing: 39] [Article Influence: 24.7] [Reference Citation Analysis]
28 Cai B, Gong Y, Wang Z, Wang L, Chen W. Microneedle arrays integrated with living organisms for smart biomedical applications. Theranostics 2021;11:10012-29. [PMID: 34815801 DOI: 10.7150/thno.66478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Rajendran ST, Scarano E, Bergkamp MH, Capria AM, Cheng CH, Sanger K, Ferrari G, Nielsen LH, Hwu ET, Zór K, Boisen A. Modular, Lightweight, Wireless Potentiostat-on-a-Disc for Electrochemical Detection in Centrifugal Microfluidics. Anal Chem 2019;91:11620-8. [PMID: 31335122 DOI: 10.1021/acs.analchem.9b02026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
30 Kjeldsen TB, Hubálek F, Tagmose TM, Pridal L, Refsgaard HHF, Porsgaard T, Gram-Nielsen S, Hovgaard L, Valore H, Münzel M, Hjørringgaard CU, Jeppesen CB, Manfè V, Hoeg-Jensen T, Ludvigsen S, Nielsen PK, Lautrup-Larsen I, Stidsen CE, Wulff EM, Garibay PW, Kodra JT, Nishimura E, Madsen P. Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320. J Med Chem 2021;64:616-28. [PMID: 33356257 DOI: 10.1021/acs.jmedchem.0c01576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
31 Chu JN, Traverso G. Foundations of gastrointestinal-based drug delivery and future developments. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34785786 DOI: 10.1038/s41575-021-00539-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Awad A, Trenfield SJ, Pollard TD, Ong JJ, Elbadawi M, McCoubrey LE, Goyanes A, Gaisford S, Basit AW. Connected healthcare: Improving patient care using digital health technologies. Adv Drug Deliv Rev 2021;178:113958. [PMID: 34478781 DOI: 10.1016/j.addr.2021.113958] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 17.0] [Reference Citation Analysis]
33 Xiao Y, Tang Z, Huang X, Joseph J, Chen W, Liu C, Zhou J, Kong N, Joshi N, Du J, Tao W. Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes. Matter 2021;4:3269-85. [DOI: 10.1016/j.matt.2021.08.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Cai X, Xu Y, Zhao L, Xu J, Li S, Wen C, Xia X, Dong Q, Hu X, Wang X, Chen L, Chen Z, Tan W. In situ pepsin-assisted needle assembly of magnetic-graphitic-nanocapsules for enhanced gastric retention and mucus penetration. Nano Today 2021;36:101032. [DOI: 10.1016/j.nantod.2020.101032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
35 Maher S, Brayden DJ. Formulation strategies to improve the efficacy of intestinal permeation enhancers. Adv Drug Deliv Rev 2021;177:113925. [PMID: 34418495 DOI: 10.1016/j.addr.2021.113925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
36 Shao J, Li KHH, Son A, Chua B. A self-powered insulin patch pump with a superabsorbent polymer as a biodegradable battery substitute. J Mater Chem B 2020;8:4210-20. [PMID: 32285906 DOI: 10.1039/d0tb00385a] [Reference Citation Analysis]
37 Stewart F, Cummins G, Turcanu MV, Cox BF, Prescott A, Clutton E, Newton IP, Desmulliez MPY, Thanou M, Mulvana H, Cochran S, Näthke I. Ultrasound mediated delivery of quantum dots from a proof of concept capsule endoscope to the gastrointestinal wall. Sci Rep 2021;11:2584. [PMID: 33510366 DOI: 10.1038/s41598-021-82240-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Tran H, ElSayed MEH. Progress and limitations of oral peptide delivery as a potentially transformative therapy. Expert Opin Drug Deliv 2022. [PMID: 35255753 DOI: 10.1080/17425247.2022.2051476] [Reference Citation Analysis]
39 Zhang Y, Zhou W, Shen L, Lang L, Huang X, Sheng H, Ning G, Wang W. Safety, Pharmacokinetics, and Pharmacodynamics of Oral Insulin Administration in Healthy Subjects: A Randomized, Double-Blind, Phase 1 Trial. Clin Pharmacol Drug Dev 2022. [PMID: 35182035 DOI: 10.1002/cpdd.1060] [Reference Citation Analysis]
40 Ahadian S, Finbloom JA, Mofidfar M, Diltemiz SE, Nasrollahi F, Davoodi E, Hosseini V, Mylonaki I, Sangabathuni S, Montazerian H, Fetah K, Nasiri R, Dokmeci MR, Stevens MM, Desai TA, Khademhosseini A. Micro and nanoscale technologies in oral drug delivery. Adv Drug Deliv Rev 2020;157:37-62. [PMID: 32707147 DOI: 10.1016/j.addr.2020.07.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 21.0] [Reference Citation Analysis]
41 Brayden DJ. The Centenary of the Discovery of Insulin: An Update on the Quest for Oral Delivery. Front Drug Deliv 2021;1:726675. [DOI: 10.3389/fddev.2021.726675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Domokos G. The Gömböc Pill. Math Intelligencer 2019;41:9-11. [DOI: 10.1007/s00283-019-09891-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Zhou X, Jiang X, Qu M, Aninwene GE 2nd, Jucaud V, Moon JJ, Gu Z, Sun W, Khademhosseini A. Engineering Antiviral Vaccines. ACS Nano 2020;14:12370-89. [PMID: 33001626 DOI: 10.1021/acsnano.0c06109] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
44 O'Neill S. News and Views: Update on technologies, medicines and treatments. Diabet Med 2019;36:913-7. [PMID: 31197889 DOI: 10.1111/dme.13965] [Reference Citation Analysis]
45 Zhang Y, Li M, Du G, Chen X, Sun X. Advancedoral vaccine delivery strategies for improving the immunity. Adv Drug Deliv Rev 2021;177:113928. [PMID: 34411689 DOI: 10.1016/j.addr.2021.113928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
46 Cummins G. Smart pills for gastrointestinal diagnostics and therapy. Adv Drug Deliv Rev 2021;177:113931. [PMID: 34416311 DOI: 10.1016/j.addr.2021.113931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
47 Liu X, Liu J, Lin S, Zhao X. Hydrogel machines. Materials Today 2020;36:102-24. [DOI: 10.1016/j.mattod.2019.12.026] [Cited by in Crossref: 127] [Cited by in F6Publishing: 50] [Article Influence: 63.5] [Reference Citation Analysis]
48 Xiao Y, Tang Z, Wang J, Liu C, Kong N, Farokhzad OC, Tao W. Plattformen für die orale Insulinabgabe: Strategien zur Beseitigung der biologischen Barrieren. Angew Chem 2020;132:19955-64. [DOI: 10.1002/ange.202008879] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Lee SH, Yoon KH. A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future. Diabetes Metab J 2021;45:629-40. [PMID: 34610718 DOI: 10.4093/dmj.2021.0163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Zhang Y, Davis DA, AboulFotouh K, Wang J, Williams D, Bhambhani A, Zakrewsky M, Maniruzzaman M, Cui Z, Williams RO 3rd. Novel formulations and drug delivery systems to administer biological solids. Adv Drug Deliv Rev 2021;172:183-210. [PMID: 33705873 DOI: 10.1016/j.addr.2021.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
51 Zhang Q, Hao S, Li L, Liu M, Huo C, Bao W, Cheng H, Fung H, Wong T, Wu W, Leung P, Wang S, Li T, Zhang G, Li M, Zhao Z, Jia W, Bian Z, Mitchison T, Zhang J, Lyu A, Han Q. M cells of mouse and human Peyer's patches mediate the lymphatic absorption of an Astragalus hyperbranched heteroglycan. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.119952] [Reference Citation Analysis]
52 Tatara AM. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks. Tissue Eng Part A 2020;26:468-74. [PMID: 32272857 DOI: 10.1089/ten.TEA.2020.0094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
53 Yang L, Zhang T, Tan R, Yang X, Guo D, Feng Y, Ren H, Tang Y, Shang W, Shen Y. Functionalized Spiral-Rolling Millirobot for Upstream Swimming in Blood Vessel. Adv Sci (Weinh) 2022;9:e2200342. [PMID: 35355442 DOI: 10.1002/advs.202200342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Stuettgen V, Brayden DJ. Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae. AAPS J 2020;22:33. [PMID: 31989362 DOI: 10.1208/s12248-020-0416-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
55 Abramson A, Frederiksen MR, Vegge A, Jensen B, Poulsen M, Mouridsen B, Jespersen MO, Kirk RK, Windum J, Hubálek F, Water JJ, Fels J, Gunnarsson SB, Bohr A, Straarup EM, Ley MWH, Lu X, Wainer J, Collins J, Tamang S, Ishida K, Hayward A, Herskind P, Buckley ST, Roxhed N, Langer R, Rahbek U, Traverso G. Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors. Nat Biotechnol 2021. [PMID: 34462588 DOI: 10.1038/s41587-021-01024-0] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
56 Lee MA, Duarte CM, Eguíluz VM, Heller DA, Langer R, Meekan MG, Sikes HD, Srivastava M, Strano MS, Wilson RP. Can Fish and Cell Phones Teach Us about Our Health? ACS Sens 2019;4:2566-70. [PMID: 31576740 DOI: 10.1021/acssensors.9b00947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Beardslee LA, Banis GE, Chu S, Liu S, Chapin AA, Stine JM, Pasricha PJ, Ghodssi R. Ingestible Sensors and Sensing Systems for Minimally Invasive Diagnosis and Monitoring: The Next Frontier in Minimally Invasive Screening. ACS Sens 2020;5:891-910. [PMID: 32157868 DOI: 10.1021/acssensors.9b02263] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 15.5] [Reference Citation Analysis]
58 Tan R, Yang X, Lu H, Yang L, Zhang T, Miao J, Feng Y, Shen Y. Nanofiber-based biodegradable millirobot with controllable anchoring and adaptive stepwise release functions. Matter 2022. [DOI: 10.1016/j.matt.2022.01.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Bhutani U, Basu T, Majumdar S. Oral Drug Delivery: Conventional to Long Acting New-Age Designs. Eur J Pharm Biopharm 2021;162:23-42. [PMID: 33631319 DOI: 10.1016/j.ejpb.2021.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Nitta T, Wang Y, Du Z, Morishima K, Hiratsuka Y. A printable active network actuator built from an engineered biomolecular motor. Nat Mater 2021;20:1149-55. [DOI: 10.1038/s41563-021-00969-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
61 Jørgensen JR, Jepsen ML, Nielsen LH, Dufva M, Nielsen HM, Rades T, Boisen A, Müllertz A. Microcontainers for oral insulin delivery – In vitro studies of permeation enhancement. European Journal of Pharmaceutics and Biopharmaceutics 2019;143:98-105. [DOI: 10.1016/j.ejpb.2019.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
62 Mazzoni C, Nielsen LH. Microdevices to successfully deliver orally administered drugs. Nanotechnology for Oral Drug Delivery. Elsevier; 2020. pp. 285-315. [DOI: 10.1016/b978-0-12-818038-9.00012-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Sun M, Ji Z, He L, Zhao C, Ma L, Xu X, Cornel EJ, Fan Z, Xu X. Instant Intracellular Delivery of miRNA via Photothermal Effect Induced on Plasmonic Pyramid Arrays. Adv Funct Materials 2022;32:2107999. [DOI: 10.1002/adfm.202107999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Field RD, Anandakumaran PN, Sia SK. Soft medical microrobots: Design components and system integration. Applied Physics Reviews 2019;6:041305. [DOI: 10.1063/1.5124007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
65 Liu D, Wang T, Lu Y. Untethered Microrobots for Active Drug Delivery: From Rational Design to Clinical Settings. Adv Healthc Mater 2022;11:e2102253. [PMID: 34767306 DOI: 10.1002/adhm.202102253] [Reference Citation Analysis]
66 Hu C, Liu W, Xu N, Huang A, Zhang Z, Fan M, Ruan G, Wang Y, Xi T, Xing Y. Silk fibroin hydrogel as mucosal vaccine carrier: induction of gastric CD4+TRM cells mediated by inflammatory response induces optimal immune protection against Helicobacter felis. Emerg Microbes Infect 2020;9:2289-302. [PMID: 33000989 DOI: 10.1080/22221751.2020.1830719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Jain KK. An Overview of Drug Delivery Systems. Methods Mol Biol 2020;2059:1-54. [PMID: 31435914 DOI: 10.1007/978-1-4939-9798-5_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
68 Min J, Yang Y, Wu Z, Gao W. Robotics in the Gut. Adv Therap 2020;3:1900125. [DOI: 10.1002/adtp.201900125] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
69 Huang WK, Xie C, Young RL, Zhao JB, Ebendorff-Heidepriem H, Jones KL, Rayner CK, Wu TZ. Development of innovative tools for investigation of nutrient-gut interaction. World J Gastroenterol 2020; 26(25): 3562-3576 [PMID: 32742126 DOI: 10.3748/wjg.v26.i25.3562] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
70 Costa C, Liu Z, Martins JP, Correia A, Figueiredo P, Rahikkala A, Li W, Seitsonen J, Ruokolainen J, Hirvonen S, Aguiar-ricardo A, Corvo ML, Santos HA. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery. Biomater Sci 2020;8:3270-7. [DOI: 10.1039/d0bm00743a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
71 Zheng Y, Xing L, Chen L, Zhou R, Wu J, Zhu X, Li L, Xiang Y, Wu R, Zhang L, Huang Y. Tailored elasticity combined with biomimetic surface promotes nanoparticle transcytosis to overcome mucosal epithelial barrier. Biomaterials 2020;262:120323. [DOI: 10.1016/j.biomaterials.2020.120323] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
72 Wook Huh H, Na YG, Kang H, Kim M, Han M, Mai Anh Pham T, Lee H, Baek JS, Lee HK, Cho CW. Novel self-floating tablet for enhanced oral bioavailability of metformin based on cellulose. Int J Pharm 2021;592:120113. [PMID: 33246050 DOI: 10.1016/j.ijpharm.2020.120113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
73 Abdelkader H, Fathalla Z, Seyfoddin A, Farahani M, Thrimawithana T, Allahham A, Alani AWG, Al-Kinani AA, Alany RG. Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants. Adv Drug Deliv Rev 2021;177:113957. [PMID: 34481032 DOI: 10.1016/j.addr.2021.113957] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
74 Cao Y, Rewatkar P, Wang R, Hasnain SZ, Popat A, Kumeria T. Nanocarriers for oral delivery of biologics: small carriers for big payloads. Trends Pharmacol Sci 2021;42:957-72. [PMID: 34593258 DOI: 10.1016/j.tips.2021.08.005] [Reference Citation Analysis]
75 Hu Y, Gao S, Lu H, Ying JY. Acid-Resistant and Physiological pH-Responsive DNA Hydrogel Composed of A-Motif and i-Motif toward Oral Insulin Delivery. J Am Chem Soc 2022;144:5461-70. [PMID: 35312303 DOI: 10.1021/jacs.1c13426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Lewis K, Strandwitz P. Microbes make metabolic mischief by targeting drugs. Nature 2019;570:453-4. [PMID: 31235939 DOI: 10.1038/d41586-019-01851-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Maikawa CL, d'Aquino AI, Lal RA, Buckingham BA, Appel EA. Engineering biopharmaceutical formulations to improve diabetes management. Sci Transl Med 2021;13:eabd6726. [PMID: 33504649 DOI: 10.1126/scitranslmed.abd6726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Hu X, Yang G, Chen S, Luo S, Zhang J. Biomimetic and bioinspired strategies for oral drug delivery. Biomater Sci 2020;8:1020-44. [PMID: 31621709 DOI: 10.1039/c9bm01378d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
79 Abramson A, Kirtane AR, Shi Y, Zhong G, Collins JE, Tamang S, Ishida K, Hayward A, Wainer J, Rajesh NU, Lu X, Gao Y, Karandikar P, Tang C, Lopes A, Wahane A, Reker D, Frederiksen MR, Jensen B, Langer R, Traverso G. Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections. Matter 2022. [DOI: 10.1016/j.matt.2021.12.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
80 Mandala VS, McKay MJ, Shcherbakov AA, Dregni AJ, Kolocouris A, Hong M. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol 2020;27:1202-8. [PMID: 33177698 DOI: 10.1038/s41594-020-00536-8] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 35.0] [Reference Citation Analysis]
81 Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Murtaza G. Recent strategies driving oral biologic administration. Expert Rev Vaccines 2021;:1-15. [PMID: 34612121 DOI: 10.1080/14760584.2021.1990044] [Reference Citation Analysis]
82 Langer R. Controlling the movement of molecules. Quart Rev Biophys 2019;52. [DOI: 10.1017/s0033583519000040] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
83 Domingo-Lopez DA, Lattanzi G, H J Schreiber L, Wallace EJ, Wylie R, O'Sullivan J, Dolan EB, Duffy GP. Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus. Adv Drug Deliv Rev 2022;185:114280. [PMID: 35405298 DOI: 10.1016/j.addr.2022.114280] [Reference Citation Analysis]
84 Li C, Zhao Y, Cheng J, Guo J, Zhang Q, Zhang X, Ren J, Wang F, Huang J, Hu H, Wang R, Zhang J. A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota. Adv Sci (Weinh) 2019;6:1900610. [PMID: 31559126 DOI: 10.1002/advs.201900610] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 19.3] [Reference Citation Analysis]
85 Lee S, Kim JY, Kim J, Hoshiar AK, Park J, Lee S, Kim J, Pané S, Nelson BJ, Choi H. A Needle-Type Microrobot for Targeted Drug Delivery by Affixing to a Microtissue. Adv Healthc Mater 2020;9:e1901697. [PMID: 32129011 DOI: 10.1002/adhm.201901697] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
86 Szunerits S, Melinte S, Barras A, Pagneux Q, Voronova A, Abderrahmani A, Boukherroub R. The impact of chemical engineering and technological advances on managing diabetes: present and future concepts. Chem Soc Rev 2021;50:2102-46. [PMID: 33325917 DOI: 10.1039/c9cs00886a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
87 Wang X, Yan J, Wang L, Pan D, Xu Y, Wang F, Sheng J, Li X, Yang M. Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy. Theranostics 2020;10:10808-22. [PMID: 32929381 DOI: 10.7150/thno.47601] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
88 Xiao Y, Tang Z, Wang J, Liu C, Kong N, Farokhzad OC, Tao W. Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers. Angew Chem Int Ed 2020;59:19787-95. [DOI: 10.1002/anie.202008879] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
89 Won C, Kwon C, Park K, Seo J, Lee T. Electronic Drugs: Spatial and Temporal Medical Treatment of Human Diseases. Adv Mater 2021;33:e2005930. [PMID: 33938022 DOI: 10.1002/adma.202005930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
90 Vinarov Z, Abrahamsson B, Artursson P, Batchelor H, Berben P, Bernkop-Schnürch A, Butler J, Ceulemans J, Davies N, Dupont D, Flaten GE, Fotaki N, Griffin BT, Jannin V, Keemink J, Kesisoglou F, Koziolek M, Kuentz M, Mackie A, Meléndez-Martínez AJ, McAllister M, Müllertz A, O'Driscoll CM, Parrott N, Paszkowska J, Pavek P, Porter CJH, Reppas C, Stillhart C, Sugano K, Toader E, Valentová K, Vertzoni M, De Wildt SN, Wilson CG, Augustijns P. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network. Adv Drug Deliv Rev 2021;171:289-331. [PMID: 33610694 DOI: 10.1016/j.addr.2021.02.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 30.0] [Reference Citation Analysis]
91 Sun M, Yue T, Wang C, Fan Z, Gazit E, Du J. Ultrasound-Responsive Peptide Nanogels to Balance Conflicting Requirements for Deep Tumor Penetration and Prolonged Blood Circulation. ACS Nano 2022. [PMID: 35475348 DOI: 10.1021/acsnano.2c01407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov 2021;20:309-25. [PMID: 33536635 DOI: 10.1038/s41573-020-00135-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 42.0] [Reference Citation Analysis]
93 Zhang X, Chen G, Fu X, Wang Y, Zhao Y. Magneto-Responsive Microneedle Robots for Intestinal Macromolecule Delivery. Adv Mater 2021;33:e2104932. [PMID: 34532914 DOI: 10.1002/adma.202104932] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
94 Dhalla AK, Al-Shamsie Z, Beraki S, Dasari A, Fung LC, Fusaro L, Garapaty A, Gutierrez B, Gratta D, Hashim M, Horlen K, Karamchedu P, Korupolu R, Liang E, Ong C, Owyang Z, Salgotra V, Sharma S, Syed B, Syed M, Vo AT, Abdul-Wahab R, Wasi A, Yamaguchi A, Yen S, Imran M. A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects. Drug Deliv Transl Res 2021. [PMID: 33604838 DOI: 10.1007/s13346-021-00938-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
95 Soto F, Wang J, Ahmed R, Demirci U. Medical Micro/Nanorobots in Precision Medicine. Adv Sci (Weinh) 2020;7:2002203. [PMID: 33173743 DOI: 10.1002/advs.202002203] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 29.5] [Reference Citation Analysis]
96 Frizzell H, Woodrow KA. Biomaterial Approaches for Understanding and Overcoming Immunological Barriers to Effective Oral Vaccinations. Adv Funct Mater 2020;30:1907170. [DOI: 10.1002/adfm.201907170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
97 Lamprou DA, Singh TR, Larrañeta E, Donnelly RF. How innovative drug delivery devices can help realize clinical utility of new effective therapies. Expert Opinion on Drug Delivery 2019;16:1277-81. [DOI: 10.1080/17425247.2019.1689956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
98 Rose F, Bloom S, Tan T. Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years. Expert Opinion on Drug Discovery 2019;14:1151-9. [DOI: 10.1080/17460441.2019.1646243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
99 Lewis AL, McEntee N, Holland J, Patel A. Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery. Drug Deliv Transl Res 2021. [PMID: 34024013 DOI: 10.1007/s13346-021-01000-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Fukada K, Tajima T, Seyama M. Thermoresponsive Gelatin/Chitosan Hydrogel Films for a Degradable Capacitor. ACS Appl Mater Interfaces 2021;13:59006-11. [PMID: 34817996 DOI: 10.1021/acsami.1c14905] [Reference Citation Analysis]
101 Uboldi M, Melocchi A, Moutaharrik S, Palugan L, Cerea M, Foppoli A, Maroni A, Gazzaniga A, Zema L. Administration strategies and smart devices for drug release in specific sites of the upper GI tract. J Control Release 2022;348:537-52. [PMID: 35690278 DOI: 10.1016/j.jconrel.2022.06.005] [Reference Citation Analysis]
102 Iyer G, Dyawanapelly S, Jain R, Dandekar P. An overview of oral insulin delivery strategies (OIDS). Int J Biol Macromol 2022;208:565-85. [PMID: 35346680 DOI: 10.1016/j.ijbiomac.2022.03.144] [Reference Citation Analysis]
103 Brayden DJ, Hill TA, Fairlie DP, Maher S, Mrsny RJ. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches. Adv Drug Deliv Rev 2020;157:2-36. [PMID: 32479930 DOI: 10.1016/j.addr.2020.05.007] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 36.5] [Reference Citation Analysis]
104 van den Bemt BJF, Gettings L, Domańska B, Bruggraber R, Mountian I, Kristensen LE. A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience. Drug Deliv 2019;26:384-92. [PMID: 30905213 DOI: 10.1080/10717544.2019.1587043] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
105 Kaffash E, Ali Shahbazi M, Hatami H, Nokhodchi A. An insight into gastrointestinal macromolecule delivery using physical oral devices. Drug Discov Today 2022:S1359-6446(22)00162-3. [PMID: 35460891 DOI: 10.1016/j.drudis.2022.04.014] [Reference Citation Analysis]
106 Gong Y, Mohd S, Wu S, Liu S, Pei Y, Luo X. pH-Responsive Cellulose-Based Microspheres Designed as an Effective Oral Delivery System for Insulin. ACS Omega 2021;6:2734-41. [PMID: 33553891 DOI: 10.1021/acsomega.0c04946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
107 Falcetta P, Aragona M, Bertolotto A, Bianchi C, Campi F, Garofolo M, Del Prato S. Insulin discovery: A pivotal point in medical history. Metabolism 2021;127:154941. [PMID: 34838778 DOI: 10.1016/j.metabol.2021.154941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Artursson P, Lundquist P. A new opening for orally taken peptide drugs. Nat Biomed Eng 2020;4:12-3. [DOI: 10.1038/s41551-019-0513-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Ferber S, Gonzalez RJ, Cryer AM, von Andrian UH, Artzi N. Immunology-Guided Biomaterial Design for Mucosal Cancer Vaccines. Adv Mater 2020;32:e1903847. [PMID: 31833592 DOI: 10.1002/adma.201903847] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
110 Mandsberg NK, Christfort JF, Kamguyan K, Boisen A, Srivastava SK. Orally ingestible medical devices for gut engineering. Adv Drug Deliv Rev 2020;165-166:142-54. [PMID: 32416112 DOI: 10.1016/j.addr.2020.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
111 Eleftheriadis GK, Katsiotis CS, Bouropoulos N, Koutsopoulos S, Fatouros DG. FDM-printed pH-responsive capsules for the oral delivery of a model macromolecular dye. Pharm Dev Technol 2020;25:517-23. [PMID: 31903821 DOI: 10.1080/10837450.2019.1711396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
112 Home PD, Mehta R. Insulin therapy development beyond 100 years. Lancet Diabetes Endocrinol 2021;9:695-707. [PMID: 34480874 DOI: 10.1016/S2213-8587(21)00182-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
113 Pathak V, Pathak NM, O'Neill CL, Guduric-Fuchs J, Medina RJ. Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419844521. [PMID: 31105434 DOI: 10.1177/1179551419844521] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
114 Mathieu C, Martens PJ, Vangoitsenhoven R. One hundred years of insulin therapy. Nat Rev Endocrinol 2021. [PMID: 34404937 DOI: 10.1038/s41574-021-00542-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
115 Kjeldsen RB, Kristensen MN, Gundlach C, Thamdrup LHE, Müllertz A, Rades T, Nielsen LH, Zór K, Boisen A. X-ray Imaging for Gastrointestinal Tracking of Microscale Oral Drug Delivery Devices. ACS Biomater Sci Eng 2021;7:2538-47. [PMID: 33856194 DOI: 10.1021/acsbiomaterials.1c00225] [Reference Citation Analysis]
116 Jørgensen JR, Thamdrup LHE, Kamguyan K, Nielsen LH, Nielsen HM, Boisen A, Rades T, Müllertz A. Design of a self-unfolding delivery concept for oral administration of macromolecules. J Control Release 2021;329:948-54. [PMID: 33086101 DOI: 10.1016/j.jconrel.2020.10.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Zhang P, Li Y, Tang W, Zhao J, Jing L, Mchugh KJ. Theranostic nanoparticles with disease-specific administration strategies. Nano Today 2022;42:101335. [DOI: 10.1016/j.nantod.2021.101335] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
118 Zizzari AT, Pliatsika D, Gall FM, Fischer T, Riedl R. New perspectives in oral peptide delivery. Drug Discov Today 2021;26:1097-105. [PMID: 33497830 DOI: 10.1016/j.drudis.2021.01.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
119 Li X, Zhao Y, Zhao C. Applications of capillary action in drug delivery. iScience 2021;24:102810. [PMID: 34296074 DOI: 10.1016/j.isci.2021.102810] [Reference Citation Analysis]
120 Luo Z, Paunović N, Leroux JC. Physical methods for enhancing drug absorption from the gastrointestinal tract. Adv Drug Deliv Rev 2021;175:113814. [PMID: 34052229 DOI: 10.1016/j.addr.2021.05.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
121 Zhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B 2021;11:2416-48. [PMID: 34522593 DOI: 10.1016/j.apsb.2021.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
122 Abramson A, Caffarel-Salvador E, Soares V, Minahan D, Tian RY, Lu X, Dellal D, Gao Y, Kim S, Wainer J, Collins J, Tamang S, Hayward A, Yoshitake T, Lee HC, Fujimoto J, Fels J, Frederiksen MR, Rahbek U, Roxhed N, Langer R, Traverso G. A luminal unfolding microneedle injector for oral delivery of macromolecules. Nat Med 2019;25:1512-8. [PMID: 31591601 DOI: 10.1038/s41591-019-0598-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
123 Sharova AS, Melloni F, Lanzani G, Bettinger CJ, Caironi M. Edible Electronics: The Vision and the Challenge. Adv Mater Technol 2021;6:2000757. [DOI: 10.1002/admt.202000757] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
124 Zhou Y, Liu L, Cao Y, Yu S, He C, Chen X. A Nanocomposite Vehicle Based on Metal–Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery. ACS Appl Mater Interfaces 2020;12:22581-92. [DOI: 10.1021/acsami.0c04303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
125 Yang J, Yang J, Gong X, Zheng Y, Yi S, Cheng Y, Li Y, Liu B, Xie X, Yi C, Jiang L. Recent Progress in Microneedles-Mediated Diagnosis, Therapy, and Theranostic Systems. Adv Healthc Mater 2022;11:e2102547. [PMID: 35034429 DOI: 10.1002/adhm.202102547] [Reference Citation Analysis]
126 Zhou Y, Chen Z, Zhao D, Li D, He C, Chen X. A pH-Triggered Self-Unpacking Capsule Containing Zwitterionic Hydrogel-Coated MOF Nanoparticles for Efficient Oral Exendin-4 Delivery. Adv Mater 2021;33:e2102044. [PMID: 34216408 DOI: 10.1002/adma.202102044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
127 Lamson NG, Fein KC, Gleeson JP, Newby AN, Xian S, Cochran K, Chaudhary N, Melamed JR, Ball RL, Suri K, Ahuja V, Zhang A, Berger A, Kolodieznyi D, Schmidt BF, Silva GL, Whitehead KA. The strawberry-derived permeation enhancer pelargonidin enables oral protein delivery. Proc Natl Acad Sci U S A 2022;119:e2207829119. [PMID: 35943988 DOI: 10.1073/pnas.2207829119] [Reference Citation Analysis]
128 Coffey JW, Gaiha GD, Traverso G. Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics. Annu Rev Pharmacol Toxicol 2021;61:517-40. [PMID: 32466690 DOI: 10.1146/annurev-pharmtox-030320-092348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
129 Christfort JF, Guillot AJ, Melero A, Thamdrup LHE, Garrigues TM, Boisen A, Zór K, Nielsen LH. Cubic Microcontainers Improve In Situ Colonic Mucoadhesion and Absorption of Amoxicillin in Rats. Pharmaceutics 2020;12:E355. [PMID: 32295139 DOI: 10.3390/pharmaceutics12040355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
130 Okeyo PO, Rajendran ST, Zór K, Boisen A. Sensing technologies and experimental platforms for the characterization of advanced oral drug delivery systems. Adv Drug Deliv Rev 2021;176:113850. [PMID: 34182015 DOI: 10.1016/j.addr.2021.113850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
131 Yang L, Hung LY, Zhu Y, Ding S, Margolis KG, Leong KW. Material Engineering in Gut Microbiome and Human Health. Research 2022;2022:1-32. [DOI: 10.34133/2022/9804014] [Reference Citation Analysis]
132 Lee JS, Han P, Chaudhury R, Khan S, Bickerton S, McHugh MD, Park HB, Siefert AL, Rea G, Carballido JM, Horwitz DA, Criscione J, Perica K, Samstein R, Ragheb R, Kim D, Fahmy TM. Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin. Nat Biomed Eng 2021;5:983-97. [PMID: 34616050 DOI: 10.1038/s41551-021-00791-0] [Reference Citation Analysis]
133 Tao W, Peppas NA. Robotic pills for gastrointestinal-tract-targeted oral mRNA delivery. Matter 2022;5:775-7. [DOI: 10.1016/j.matt.2022.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Zhao C, Cai L, Nie M, Shang L, Wang Y, Zhao Y. Cheerios Effect Inspired Microbubbles as Suspended and Adhered Oral Delivery Systems. Adv Sci (Weinh) 2021;8:2004184. [PMID: 33854900 DOI: 10.1002/advs.202004184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
135 Lorscheider M, Gaudin A, Nakhlé J, Veiman KL, Richard J, Chassaing C. Challenges and opportunities in the delivery of cancer therapeutics: update on recent progress. Ther Deliv 2021;12:55-76. [PMID: 33307811 DOI: 10.4155/tde-2020-0079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
136 Heise T. The future of insulin therapy. Diabetes Res Clin Pract 2021;175:108820. [PMID: 33865915 DOI: 10.1016/j.diabres.2021.108820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
137 Ciuti G, Skonieczna-Żydecka K, Marlicz W, Iacovacci V, Liu H, Stoyanov D, Arezzo A, Chiurazzi M, Toth E, Thorlacius H, Dario P, Koulaouzidis A. Frontiers of Robotic Colonoscopy: A Comprehensive Review of Robotic Colonoscopes and Technologies. J Clin Med 2020;9:E1648. [PMID: 32486374 DOI: 10.3390/jcm9061648] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
138 Iyengar ARS, Gupta S, Jawalekar S, Pande AH. Protein Chimerization: A New Frontier for Engineering Protein Therapeutics with Improved Pharmacokinetics. J Pharmacol Exp Ther 2019;370:703-14. [DOI: 10.1124/jpet.119.257063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
139 Zhao X, Zhang H, Li J, Tian M, Yang J, Sun S, Hu Q, Yang L, Zhang S. Orally administered saccharide-sequestering nanocomplex to manage carbohydrate metabolism disorders. Sci Adv 2021;7:eabf7311. [PMID: 33789906 DOI: 10.1126/sciadv.abf7311] [Reference Citation Analysis]
140 Yazdi MK, Zarrintaj P, Bagheri B, Kim YC, Ganjali MR, Saeb MR. Nanotechnology-based biosensors in drug delivery. Nanoengineered Biomaterials for Advanced Drug Delivery. Elsevier; 2020. pp. 767-79. [DOI: 10.1016/b978-0-08-102985-5.00032-2] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
141 Abraham-ekeroth RM. Radioplasmonics: Design of Metamaterial Milli-particles in Air and Absorbing Media for Antenna Communication and Human-Body In Vivo Applications. Plasmonics 2021;16:2179-91. [DOI: 10.1007/s11468-021-01471-0] [Reference Citation Analysis]
142 Maher S, Geoghegan C, Brayden DJ. Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans. Expert Opin Drug Deliv 2021;18:273-300. [PMID: 32937089 DOI: 10.1080/17425247.2021.1825375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
143 Jørgensen JR, Yu F, Venkatasubramanian R, Nielsen LH, Nielsen HM, Boisen A, Rades T, Müllertz A. In Vitro, Ex Vivo and In Vivo Evaluation of Microcontainers for Oral Delivery of Insulin. Pharmaceutics 2020;12:E48. [PMID: 31936066 DOI: 10.3390/pharmaceutics12010048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
144 Sigurdarson NS, Eifler T, Ebro M, Papalambros PY. Multiobjective Monotonicity Analysis: Pareto Set Dependency and Trade-Offs Causality in Configuration Design. Journal of Mechanical Design 2022;144:031704. [DOI: 10.1115/1.4052444] [Reference Citation Analysis]